Traditional Chinese medicine (TCM) offers a fascinating route for investigating possible inhibitors targeting Phosphoserine Aminotransferase 1 (PSAT1) in early-stage ovarian cancer [5]. This evidence concerns the gene PSAT1 and ovarian cancer.